(PGJ) Invesco Golden Dragon China - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46137V5710

PGJ: Stocks, Equities, Chinese, Companies

The Invesco Golden Dragon China ETF (PGJ) is an exchange-traded fund that focuses on U.S. exchange-listed companies with ties to China, specifically those headquartered or incorporated in the Peoples Republic of China. By investing at least 90% of its assets in the underlying indexs securities, the fund provides a targeted exposure to Chinese companies listed in the U.S.

The funds non-diversified nature means it may be more susceptible to market fluctuations related to the Chinese economy and geopolitical tensions between China and the U.S. However, this also allows for a more concentrated investment in a specific segment of the market, potentially leading to higher returns if the sector performs well.

From a technical standpoint, the recent price action of PGJ indicates a potential bullish trend. The last price of $29.34 is above both the 50-day SMA of $28.47 and the 200-day SMA of $26.37, suggesting a positive momentum. The 20-day SMA of $27.27 further supports this, as the price has bounced back from this level. The ATR of 0.90, or 3.08% of the last price, indicates a moderate level of volatility, which is expected given the funds focus on a specific and potentially volatile market segment.

Considering the current technical and fundamental data, a forecast for PGJ could be constructed. With the current price above key moving averages and a relatively stable volatility profile, the fund is poised for potential growth if the underlying Chinese companies continue to perform well. However, the AUM of $142.66M suggests that the fund is not overly large, which could impact liquidity. If the 52-week high of $32.49 is retested, PGJ could potentially see a further increase, driven by the underlying indexs performance. Conversely, a decline below the 200-day SMA could signal a downturn. Therefore, a likely forecast is that PGJ will continue to be influenced by the performance of Chinese companies listed in the U.S., with a potential target near the 52-week high if the current trend persists.

Additional Sources for PGJ ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

PGJ ETF Overview

Market Cap in USD 142m
Category China Region
TER 0.70%
IPO / Inception 2004-12-09

PGJ ETF Ratings

Growth Rating -22.2
Fundamental -
Dividend Rating 59.4
Rel. Strength 7.66
Analysts -
Fair Price Momentum 26.34 USD
Fair Price DCF -

PGJ Dividends

Dividend Yield 12m 4.75%
Yield on Cost 5y 3.04%
Annual Growth 5y 44.54%
Payout Consistency 78.1%
Payout Ratio %

PGJ Growth Ratios

Growth Correlation 3m -14.1%
Growth Correlation 12m 70.5%
Growth Correlation 5y -68.8%
CAGR 5y -8.04%
CAGR/Max DD 5y -0.10
Sharpe Ratio 12m -0.20
Alpha 10.26
Beta 0.727
Volatility 29.23%
Current Volume 23.3k
Average Volume 20d 25.1k
What is the price of PGJ shares?
As of June 16, 2025, the stock is trading at USD 28.18 with a total of 23,274 shares traded.
Over the past week, the price has changed by -0.70%, over one month by -2.63%, over three months by -7.36% and over the past year by +19.74%.
Is Invesco Golden Dragon China a good stock to buy?
Neither. Based on ValueRay´s Analyses, Invesco Golden Dragon China is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -22.21 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PGJ is around 26.34 USD . This means that PGJ is currently overvalued and has a potential downside of -6.53%.
Is PGJ a buy, sell or hold?
Invesco Golden Dragon China has no consensus analysts rating.
What are the forecasts for PGJ share price target?
According to our own proprietary Forecast Model, PGJ Invesco Golden Dragon China will be worth about 29.6 in June 2026. The stock is currently trading at 28.18. This means that the stock has a potential upside of +5.04%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 29.6 5%